![Nikolaus Spieckermann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Nikolaus has close to ten years experience in corporate finance, consulting and Venture Capital.
Prior to joining gcp in 2003, he worked for Vienna-based technology VC investor Invest Equity early stage and spent several years with London-based strategy consultancy The COBA Group (now PwC Transaction Services), where he was involved in over 30 PE/VC transactions in the UK and across the continent.
He is fluent in English and French.
Nikolaus is an ardent telemark skier and is actively involved in primary-healthcare projects in Burkina Faso, West Africa, managed by Vienna/Ouagadougou-based NGO laafi, which he co-founded in 1994.
Core Expertise: Corporate finance, investment appraisal & structuring, strategy & business development.
Sectors: Life Sciences (Biopharmaceuticals and MedTech) and Communication & Network Industries.
Academic achievements: MA Business & Commerce, Vienna University of Business & Economics and IECS Strasburg; MSc Political Economy, London School of Economics & Political Science
Investments:
Biopharmaceuticals
Oridis Biomed
Eucodis
igeneon AG (Aphton)
Communications & Networks
inode
Medical Devices
Pro-Med AG
Software
r.z.w.
cimdata AG
Anciens postes connus de Nikolaus Spieckermann
| Sociétés | Poste | Fin |
|---|---|---|
gcp gamma capital partners Beratungs- & Beteiligungs GmbH
 gcp gamma capital partners Beratungs- & Beteiligungs GmbH Investment ManagersFinance GCP is a long-term, hands-on manager which invests in dynamic early-stage growth companies in the information & communication technologies and the life sciences (biopharmaceuticals and medical devices) sectors. They invest across the EU with a focus on early-stage and expansion projects in German-speaking Europe and the EU countries bordering Austria and consider investments outside this area which meet specific conditions. The firm has special expertise in supply chain management and logistics solutions, data processing & analysis, IP-related communication services, telecom, telecom infrastructure, RFID, chip design, semiconductor IP, immunology, oncology, metabolic diseases and genetic diversity. They do not invest in purely marketing-driven concepts, media projects or services. The firm typically seeks to invest EUR 0.5-4 million in companies with a strong, defendable IP position, an innovative technological solution, an outstanding management team, a simple, compelling business idea with a clear and plausible business model, explosive growth potential and a plausible exit opportunity within the lifetime of their funds. In larger rounds, they usually invest in syndication with venture capital partners. GCP takes significant stakes and seeks board representation in their investee companies, partnering with management to lend strategic support to accelerate growth and create value, optimize capital structure and access additional financing through their partners. | Private Equity Investor | 31/12/2010 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
gcp gamma capital partners Beratungs- & Beteiligungs GmbH
gcp gamma capital partners Beratungs- & Beteiligungs GmbH Investment ManagersFinance GCP is a long-term, hands-on manager which invests in dynamic early-stage growth companies in the information & communication technologies and the life sciences (biopharmaceuticals and medical devices) sectors. They invest across the EU with a focus on early-stage and expansion projects in German-speaking Europe and the EU countries bordering Austria and consider investments outside this area which meet specific conditions. The firm has special expertise in supply chain management and logistics solutions, data processing & analysis, IP-related communication services, telecom, telecom infrastructure, RFID, chip design, semiconductor IP, immunology, oncology, metabolic diseases and genetic diversity. They do not invest in purely marketing-driven concepts, media projects or services. The firm typically seeks to invest EUR 0.5-4 million in companies with a strong, defendable IP position, an innovative technological solution, an outstanding management team, a simple, compelling business idea with a clear and plausible business model, explosive growth potential and a plausible exit opportunity within the lifetime of their funds. In larger rounds, they usually invest in syndication with venture capital partners. GCP takes significant stakes and seeks board representation in their investee companies, partnering with management to lend strategic support to accelerate growth and create value, optimize capital structure and access additional financing through their partners. | Finance |
Choisissez Zonebourse 
